Bone mineral density in transfusion-dependent thalassemia patients and its associated factors in Southern Iran

Mohammadreza Bordbar1, Gholamhossein Ranjbar Omrani2, Sezaneh Haghpanah1

  • 1Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, IR, Iran.

Archives of Osteoporosis
|September 21, 2020
PubMed

Insights

Low bone mass is common in transfusion-dependent thalassemia (TDT) patients. Insufficient physical activity and hypogonadism are key factors, alongside diabetes mellitus and low sun exposure, contributing to this complication.

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Hematology

Background:

  • Transfusion-dependent thalassemia (TDT) management has improved, but long-term complications remain a concern.
  • Low bone mass is a significant and prevalent complication in TDT patients.

Purpose of the Study:

  • To investigate the prevalence of low bone mass in TDT patients.
  • To identify associated factors contributing to low bone mass in this population.

Main Methods:

  • A cross-sectional study involving 615 TDT patients and a control group.
  • Assessment of bone mineral density, serum biochemical tests, physical activity, and sun exposure.
  • Clinical examination by an endocrinologist.

Main Results:

  • The prevalence of low bone mass was high in TDT patients (48.3% femoral, 74.6% lumbar).
  • Common endocrinopathies included hypogonadism (49.8%) and diabetes mellitus (17.2%).
  • Low bone mass was associated with insufficient physical activity, hypogonadism, diabetes mellitus, and inadequate sun exposure.

Conclusions:

  • Low bone mass is highly prevalent in transfusion-dependent thalassemia patients in Southern Iran.
  • Insufficient physical activity and hypogonadism are primary associated factors, with diabetes mellitus and low sun exposure also contributing.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
691
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
105
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
4.9K
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
212
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
1.9K